Megan Sniecinski
About Megan Sniecinski
Megan Sniecinski is an experienced business executive with a background in pharmaceuticals, having served as Chief Business Officer at BioCryst Pharmaceuticals and held senior leadership roles at PTC Therapeutics.
Chief Business Officer at BioCryst Pharmaceuticals
Megan Sniecinski served as the Chief Business Officer at BioCryst Pharmaceuticals from July 2019 to August 2021. In this role, she was responsible for overseeing business operations and strategic initiatives. During her tenure, she contributed to the company's growth and expansion efforts. BioCryst Pharmaceuticals focuses on the discovery and development of novel oral and injectable small-molecule medicines to meet the needs of patients with rare and serious diseases.
Senior Leadership at PTC Therapeutics, Inc.
From September 2014 to June 2019, Megan Sniecinski held multiple senior leadership roles at PTC Therapeutics, Inc. She advanced to the position of senior vice president of business operations and program management. Her responsibilities included overseeing company operations and managing key programs. PTC Therapeutics is dedicated to the discovery and development of clinically differentiated medicines for patients with rare disorders.
Career at Merck
Megan Sniecinski worked at Merck for over 12 years, where she held various operational and strategic roles. Throughout her career at Merck, she gradually took on more responsibility, contributing significantly to the company's operations. Merck is a global pharmaceutical company known for its innovative treatments and medicines.
Education in Chemical Engineering
Megan Sniecinski received a Bachelor of Science degree in Chemical Engineering from the University of Virginia. This strong technical foundation prepared her for a career in the pharmaceutical and biotechnology industries, where she has applied her engineering skills to various strategic and operational roles.
MBA from Wharton School of the University of Pennsylvania
Megan Sniecinski earned an MBA from the Wharton School of the University of Pennsylvania. This advanced degree equipped her with the business acumen and leadership skills necessary for high-level executive roles in the pharmaceutical industry. The Wharton School is renowned for its rigorous MBA program that emphasizes leadership and management.